Literature DB >> 8394385

Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement.

E Percivalle1, M G Revello, L Vago, F Morini, G Gerna.   

Abstract

Giant cells fully permissive for human cytomegalovirus (HCMV) were found to circulate, at a variable proportion, in peripheral blood of 21 out of 25 immunocompromised patients with disseminated HCMV infection. Circulating endothelial giant cells (EGC) were identified by a specific monoclonal antibody of endothelial origin and shown to express immediate-early, early, and late viral proteins. Immunostaining patterns of different viral proteins were comparable to those detected in vitro in cultured human umbilical vein endothelial cells. EGC counts > 10 were associated with high levels (> 100) of HCMV viremia and antigenemia, as well as with an overt clinical syndrome in transplanted patients, and to an untreated long lasting organ localization in AIDS patients. On the other hand, EGC counts were < 10 during disseminated HCMV infections of both transplant recipients with no apparent organ syndrome and AIDS patients with recent organ involvement. In tissue sections from AIDS patients, infected endothelial cells were found to progressively enlarge till detaching from the small vessel wall and entering blood stream. HCMV-infected EGC represent a new systemic parameter suitable for the diagnosis of HCMV organ involvement and for the study of the pathogenesis of disseminated infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394385      PMCID: PMC294899          DOI: 10.1172/JCI116635

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.

Authors:  G Gerna; M G Revello; E Percivalle; M Zavattoni; M Parea; M Battaglia
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

2.  Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization.

Authors:  W M Dankner; J A McCutchan; D D Richman; K Hirata; S A Spector
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

3.  High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis.

Authors:  M G Hendrix; M M Salimans; C P van Boven; C A Bruggeman
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

4.  The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients.

Authors:  M G Hendrix; P H Dormans; P Kitslaar; F Bosman; C A Bruggeman
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

5.  Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues.

Authors:  C B Toorkey; D R Carrigan
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

6.  Cytomegalovirus nucleic acid distribution within the human vascular tree.

Authors:  M G Hendrix; M Daemen; C A Bruggeman
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

7.  Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia.

Authors:  G Gerna; D Zipeto; M Parea; M G Revello; E Silini; E Percivalle; M Zavattoni; P Grossi; G Milanesi
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

8.  Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages.

Authors:  J L Lathey; S A Spector
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Human cytomegalovirus productively infects primary differentiated macrophages.

Authors:  C E Ibanez; R Schrier; P Ghazal; C Wiley; J A Nelson
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients.

Authors:  M G Revello; E Percivalle; A Di Matteo; F Morini; G Gerna
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

View more
  38 in total

1.  Origins of circulating endothelial cells and endothelial outgrowth from blood.

Authors:  Y Lin; D J Weisdorf; A Solovey; R P Hebbel
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  The intracellular localization of human cytomegalovirus DNA in peripheral blood leukocytes during active infections by high-resolution fluorescence in situ hybridization.

Authors:  H Hackstein; H Kirchner; G Jahn; G Bein
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  A sensitive method for quantifying cytomegalic endothelial cells in peripheral blood from cytomegalovirus-infected patients.

Authors:  A M Kas-Deelen; M C Harmsen; E F de Maar; W J van Son; T H The
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

4.  Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.

Authors:  P Grossi; S Kusne; C Rinaldo; K St George; M Magnone; J Rakela; J Fung; T E Starzl
Journal:  Transplantation       Date:  1996-06-15       Impact factor: 4.939

Review 5.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains.

Authors:  M Kahl; D Siegel-Axel; S Stenglein; G Jahn; C Sinzger
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion.

Authors:  Marco Patrone; Massimiliano Secchi; Loretta Fiorina; Mariagrazia Ierardi; Gabriele Milanesi; Andrea Gallina
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.

Authors:  R Mañez; S Kusne; M Green; K Abu-Elmagd; W Irish; J Reyes; H Furukawa; A Tzakis; J J Fung; S Todo
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

9.  Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Authors:  Annalisa Macagno; Nadia L Bernasconi; Fabrizia Vanzetta; Erica Dander; Antonella Sarasini; Maria Grazia Revello; Giuseppe Gerna; Federica Sallusto; Antonio Lanzavecchia
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures.

Authors:  Yoshihiro Tsutsui; Hideya Kawasaki; Isao Kosugi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.